Skip to main content

Table 4 Association between hTERT polymorphisms and clinicopathological characteristics

From: Association between hTERT polymorphisms and the risk of breast cancer in a sample of Southeast Iranian population

Variables MNS16A p rs2735940 p rs2736098 p
  LL LS SS   CC CT TT   AA AG GG  
Age (years)     0.123     0.181     0.893
 ≤50 58 83 7   21 70 57   21 82 39  
 >50 56 48 7   24 52 33   17 57 30  
Pathological type     0.812     0.704     
 Ductal 78 87 10   30 85 60   30 91 45 0.351
 Others 37 49 5   15 39 35   10 49 28  
Tumor size (cm)     0.429     0.427     0.575
 ≤2 35 47 6   12 44 32   14 48 19  
 >2 77 79 7   33 76 54   22 89 46  
TNM Stage     0.850     0.237     0.595
 I 19 22 3   7 25 12   8 27 8  
 II 47 48 5   19 41 40   12 51 32  
 III 32 35 3   14 38 17   12 37 17  
 IV 13 24 2   5 17 17   4 21 11  
Grade     0.437     0.072     0.286
 I 23 21 2   10 19 17   10 20 14  
 II 64 67 7   18 62 58   17 81 34  
 III 14 30 1   11 26 8   6 22 15  
 IV 0 0 0   0 1 0   0 0 0  
ER status     0.858     0.090     0.260
 Positive 68 78 8   26 81 47   23 79 46  
 Negative 37 43 3   15 32 36   14 47 16  
PgR status     0.627     0.620     0.137
 Positive 62 79 6   28 71 48   18 80 42  
 Negative 41 42 5   13 42 33   19 44 20  
HER2 status     0.155     0.404     0.186
 Positive 50 69 9   27 59 42   15 75 32  
 Negative 61 59 4   18 60 45   22 59 36